The FCF Healthcare & Life Sciences Venture Capital Monitor – USA is a monthly published overview of venture capital trends in the US Healthcare & Life Sciences sector.
As of the end of November 2024 we identified the following current VC trends in the United States:
- Total Healthcare & Life Sciences funding reached EUR 32,558m
- Biotech/Pharma received 53% of the total investment volume (EUR 17,215m) with oncology being the leading indication (28%)
- In November Trace Neuroscience secured the highest transaction volume with EUR 93m, followed by TrexBio with EUR 78m and ZAP Surgical with EUR 72m
- RA Capital Management (United States) is the most active investor (by deal volume in 2024), followed by ARCH Venture Partners (United States) and Atlas Venture (United States)
Capital Markets Research
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 11/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 11/2024”. The Monitor is a monthly published overview of venture capital trends
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 11/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 11/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024”. The Monitor is a monthly published overview of venture capital trends in
